Built to last: Integrating resilience within the pharmaceutical supply chain

Abstract

Purpose

This paper aims to review the latest management developments across the globe and pinpoint practical implications from cutting-edge research and case studies.

Design/methodology/approach

This briefing is prepared by an independent writer who adds their own impartial comments and places the articles in context.

Findings

This paper investigated the different resilience strategies that can be applied within the pharmaceutical supply chain.

Originality/value

The briefing saves busy executives, strategists and researchers hours of reading time by selecting only the very best, most pertinent information and presenting it in a condensed and easy-to-digest format.

Citation

(2023), "Built to last: Integrating resilience within the pharmaceutical supply chain", Strategic Direction, Vol. 39 No. 5, pp. 5-6. https://doi.org/10.1108/SD-03-2023-0042